Author

Eman Soliman

Zagazig University - Cited by 600 - pharmacology

Biography

Eman Soliman is an Ph.D student studied the molecular mechanism of an endocannabinod as a selective treatment for Non Melanoma skin Cancer. As a post doc, I am testing the selective toxicity of endocannabinoids as well as other compounds against colorectal cancer.            
Title
Cited by
Year
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
D Ladin, E Soliman, LT Griffin, R Van DrossFrontiers in Pharmacology 7, 361, 2016201
106
2016
Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice
AJ Kiraly, E Soliman, A Jenkins, RT Van DrossProstaglandins, Leukotrienes and Essential Fatty Acids 104, -53, 2016201
44
2016
PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury
S Elshazly, E SolimanToxicology and applied pharmacology 362, 86-94, 2019201
44
2019
43
2019
Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms
K Soderstrom, E Soliman, R Van DrossFrontiers in Pharmacology 8, 720, 2017201
39
2017
Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth
R Van Dross, E Soliman, S Jha, T Johnson, S MukhopadhyayLife Sciences 92 (8-9), 463-466, 2013201
31
2013
Heme-dependent ER stress apoptosis: a mechanism for the selective toxicity of the dihydroartemisinin, NSC735847, in colorectal cancer cells
AEM Elhassanny, E Soliman, M Marie, P McGuire, W Gul, M ElSohly, ...Frontiers in Oncology 10, 965,
20
2020
Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and …
A Sakr, S Rezq, SM Ibrahim, E Soliman, MM Baraka, DG Romero, ...Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1810-1828, 2021202
19
2021
SYNTHESIS AND EVALUATION OF THE NOVEL PROSTAMIDE, 15-DEOXY, Δ12, 14-PROSTAMIDE J2, AS A SELECTIVE ANTI-TUMOR THERAPEUTIC
DA Ladin, E Soliman, R Escobedo, TL Fitzgerald, LV Yang, C Burns, ...Molecular Cancer Therapeutics, molcanther. 0484.2016, 202
17
2017
Antidepressant activity of anti-hyperglycemic agents in experimental models: A review
N Essmat, E Soliman, MF Mahmoud, AAA MahmoudDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020202
16
2020
Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease
E Soliman, AEM Elhassanny, A Malur, M McPeek, A Bell, N Leffler, ...Toxicology 445, 152598, 2020202
14
2020
Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants
AEM Elhassanny, DA Ladin, E Soliman, H Albassam, A Morris, R Kobet, ...Prostaglandins & Other Lipid Mediators 2, 9-23, 2019201
14
2019
Matrix Metalloproteinase-12 is Required for Granuloma Progression
A Mohan, N Neequaye, A Malur, E Soliman, M McPeek, N Leffler, ...Frontiers in immunology, doi: 10.3389/fimmu.2020.553949, 2020202
14
2020
Cannabinoids as Therapeutics for Non-Melanoma and Melanoma Skin Cancer
E Soliman, D Ladin, R Van DrossJournal of Dermatology and Clinical Research 4 (2), 1069, 2016201
12
2016
Type I Interferon Response is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury
LE Fritsch, J Ju, EK Gudenschwager Basso, E Soliman, S Paul, J Chen, ...Frontiers in Molecular Neuroscience, 53, 2022202
7
2022
Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway
NM Mahmoud, SM Elshazly, AA Hassan, E SolimanInternational Immunopharmacology 11, 109646, 2023202
5
2023
PPARγ Deficiency in Carbon Nanotube-elicited Granulomatous Inflammation Promotes a Th17 Response to a Microbial Antigen
V Sanderford, BP Barna, RA Barrington, A Malur, A Mohan, N Leffler, ...Journal of Nanomedicine & Nanotechnology 11 (1), doi: 10.3248/217-7439.20 …, 2020202
5
2020
Conditional deletion of EphA4 on Cx3cr1-expressing microglia fails to influence histopathological outcome and blood brain barrier disruption following TBI
E Soliman, J Mills, J Ju, A Kaloss, C Kelly, EA Kowalski, M Elhassanny, ...Frontiers in Molecular Neuroscience, 196, 2021202
5
2021